Glaxo Smith Kline operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Glaxo Smith Kline with three other
companies in this sector in Egypt:
Alexandria Pharmaceuticals and Chemical Industries Co
sales of 382.89 million Egyptian Pounds [US$20.48 million]
Memphis Pharmaceutical & Chemical Industries
(396.15 million Egyptian Pounds [US$21.19 million]
Egypt International Pharmaceuticals
(1.70 billion Egyptian Pounds [US$90.75 million]
of which 100%
During the year ended December of 2015, sales at
Glaxo Smith Kline were 1.02 billion Egyptian Pounds (US$54.60 million).
decrease of 3.9%
versus 2014, when the company's sales were 1.06 billion Egyptian Pounds.